Patents for C12P 21 - Preparation of peptides or proteins (112,499)
07/2008
07/31/2008US20080181883 Purified Antigen for Alzheimer's Disease and Methods of Obtaining and Using Same
07/31/2008CA2676651A1 Use of chick beta actin gene intron-1
07/31/2008CA2676529A1 Genetically recombinant antibody composition having enhanced effector activity
07/31/2008CA2675293A1 Cancerous disease modifying antibodies
07/31/2008CA2675292A1 Cancerous disease modifying antibodies
07/31/2008CA2674897A1 Cancerous disease modifying antibodies
07/30/2008EP1950302A2 Streptococcus antigens
07/30/2008EP1950301A2 Antibody for use in Therapy
07/30/2008EP1950300A2 Antibody variants with higher binding affinity compared to parent antibodies
07/30/2008EP1950298A2 Hemoglobin mutants with increased soluble expression and/or reduced nitric oxide scavenging
07/30/2008EP1950226A2 Receptors for human interleukin-12
07/30/2008EP1950225A1 Method for increasing protein yield
07/30/2008EP1950224A2 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
07/30/2008EP1950223A2 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
07/30/2008EP1950221A2 Genomic sequences of exported mycobacteria polypeptides, vectors containing them and applications to the diagnosis and prevention of tuberculosis
07/30/2008EP1948818A2 Use of b cell expansion agents in generating antibodies
07/30/2008EP1948817A1 Cell-free in vitro transcription and translation of membrane proteins into tethered planar lipid layers
07/30/2008EP1948802A1 Chimeric antigen containing hepatitis c virus polypeptide and fc fragment for eliciting an immune response
07/30/2008EP1948799A1 Use of bacteriocins for promoting plant growth and disease resistance
07/30/2008EP1948798A1 Anti-alpha2 integrin antibodies and their uses
07/30/2008EP1948785A2 Glp-2 mimetibodies, polypeptides, compositions, methods and uses
07/30/2008EP1948234A2 Compositions and methods for the treatment and prevention of fibrotic, inflammatory and neovascularization conditions
07/30/2008EP1442295B1 Periostin-based diagnostic assays
07/30/2008EP1423525B1 Recombinant mva capable of expressing structural hcv antigens
07/30/2008EP1186616B1 Antifucoidan antibody
07/30/2008EP1144600B1 Akt-3 nucleic acids, polypeptides, and uses thereof
07/30/2008EP1076065B1 Polypeptide having antihuman immunodeficiency virus activity, gene encoding the polypeptide and process for producing the polypeptide
07/30/2008EP0994728B1 Recombinant antibodies specific for beta-amyloid ends, dna encoding and methods of use thereof
07/30/2008EP0912738B1 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
07/30/2008EP0776209B1 Polynucleic acids and proteins from a porcine reproductive and respiratory syndrome virus and uses thereof
07/30/2008EP0659276B2 Immunoassay for detecting collagen or collagen fragments
07/30/2008CN101233238A Serum-free stable transfection and production of recombinant human proteins in human cell lines
07/30/2008CN101230377A Method for preparing antioxidant collagen peptide by spent of ocean alkaline protease 894 hydrolyzed aquatic products processing
07/30/2008CN101230376A Enzymolysis liquid deodouring and decolouring method for aquatic products processing spent
07/30/2008CN101230375A Jellyfish original glycoprotein having fatigue resistant activity and preparation technique thereof
07/30/2008CN101230345A Multiple promoters and their use for gene expression
07/30/2008CN101230340A 纤维蛋白溶解活性多肽 Fibrinolytic activity of the polypeptide
07/30/2008CN101230104A Recombinant protein containing a c-terminal fragment of plasmodium msp-1
07/30/2008CN101230088A Method for extracting native natural collagen from animal skin or/and tendon
07/30/2008CN100406562C Humanized immunoglobulin reactive with alpha 4 beta 7 integrin
07/30/2008CN100406558C Method for preparing recombinant aprotinin
07/30/2008CN100406472C Fusion and solubility expression of cobratoxin and acidolysis release and purification of recombinant toxin
07/30/2008CN100406469C Novel protein, gene encoding the same and method of utilization thereof
07/29/2008US7405288 V-like domain binding molecules and polynucleotides encoding therefor
07/29/2008US7405276 First antigen recognition portion that binds a C3b-like receptor and a second that binds an antigenic molecule present in the circulatory system
07/29/2008US7405275 Nucleic acid and vectors encodes antibodies ; antigen binding fragments
07/29/2008US7405274 Monoclonal antibodies for use in diagnosis and treatment of diabetes, hypertension, hyperglycemia and congestive heart failure
07/29/2008US7405272 Selectin ligand interactor cytoplasmic (SLIC-1), a P-selectin glycoprotein ligand (PSGL-1) binding protein
07/29/2008US7405269 Identification and isolation of novel DNA and recombinant production of novel polypeptides
07/29/2008US7405077 Sperm protein 17 for the diagnosis and treatment of cancer
07/29/2008US7405074 Glyphosate-N-acetyltransferase (GAT) genes
07/29/2008US7405064 Nucleic acid fragments encoding nitrile hydratase and amidase enzymes from Comamonas testosteroni 5-MGAM-4D and recombinant organisms expressing those enzymes useful for the production of amides and acids
07/29/2008US7405061 for drug screening/diagnosis and/or treatment of a variety of human diseases and cancers; immunotherapy; genetic engineering
07/29/2008US7405060 Gene amplification methods
07/29/2008US7405058 Thymic stromal lymphopoietin (TSLP); nucleic acid encoding polypeptide of given sequence; use in peptide fragmentation studies and molecular weight measurements
07/29/2008US7405048 Improving production by immunocompetent cells; side effect reduction
07/29/2008US7405038 Baculovirus expressing recombinant protein with gene inhibiting apoptosis
07/29/2008US7404957 Interleukins; for treatment of respiratory disorders such as asthma, chronic obstructive pulmonary disease, emphysema, and bronchitis; improved plasma half-life
07/29/2008US7404956 Immunoglobulin chimeric monomer-dimer hybrids
07/29/2008US7404954 Drug delivery using Polymeric immunoglobulin receptor (pIgR) which when cleaved has a stalk region which remains attached to the cell and a secretory component (SC) which exists in an organ of interest in several forms
07/29/2008US7404270 Tumor antigen
07/29/2008CA2192543C Interleukin-5 specific recombinant antibodies
07/29/2008CA2160121C T cell epitopes of the major allergens from dermatophagoides (house dust mite)
07/29/2008CA2141842C Novel glycoforms of soluble complement receptor 1
07/24/2008WO2008088884A2 Enhanced cell-free synthesis of active proteins containing disulfide bonds
07/24/2008WO2008088837A2 Expression of hla proteins on non-human cells
07/24/2008WO2008088757A2 Apparatus and methods for osmotically shocking cells
07/24/2008WO2008088548A2 Disintegrin variants and pharmaceutical uses thereof
07/24/2008WO2008066583A9 Cell-free synthesis of proteins containing unnatural amino acids
07/24/2008WO2008036600A3 Methods of protein production
07/24/2008WO2007109697A3 The use of protein s fusion for protein solubilization
07/24/2008WO2007089793A3 Tat-041 and methods of assessing and treating cancer
07/24/2008WO2004090101A3 Epoxide hydrolases, nucleic acids encoding them and methods for making and using them
07/24/2008WO2004082598A3 Relaxin3-gpcr135 complexes and their production and use
07/24/2008WO2004071573A3 Hypoxia induced mitogenic factor
07/24/2008US20080178355 Transcription factor stress-related polypeptides and methods of use in plants
07/24/2008US20080177046 Soluble Form of Carbonic Anhydrase IX (s-CA IX), Assays to Detect s-CA IX, CA IX's Coexpression with Her-2/neu/c-erbB-2, and CA IX-Specific Monoclonal Antibodies to Non-Immunodominant Epitopes
07/24/2008US20080177044 Novel saitohin gene and uses of same
07/24/2008US20080177043 Vascular endothelial growth factor receptor specific immunoglobulin for diagnosis, prevention and treatment of cell proliferative disorders
07/24/2008US20080177038 Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides
07/24/2008US20080176944 Elongase Genes and Uses Thereof
07/24/2008US20080176798 Compounds and methods for diagnosis and immunotherapy of tuberculosis
07/24/2008US20080176790 mutants of fibroblast growth factors containing N-linked or O-linked glycosylation sites ;drug-polymer conjugates, used for treating fibroblast growth factor deficiency in patients
07/24/2008US20080176788 Apo-2 ligand
07/24/2008US20080176323 Expression vector comprising nucleotide sequences coding cytokine polypeptide for use in treatment and prevention of lung, viral, cell proliferative and inflammatory diseases
07/24/2008US20080176310 Carbonic anhydrase for use diagnostic/prognostic tool in detectingf cell proliferative disorders of breast
07/24/2008US20080176288 Colony stimulating factor fusion protein comprising polyanionic polymer for use tool to enhance drug delivery
07/24/2008US20080176287 Highly phosphorylated and sulfated recombinant factor ix
07/24/2008US20080176286 Method for making monoclonal antibodies and cross-reactive antibodies obtainanble by the method
07/24/2008US20080176285 N-acetyl glucosamine phosphotransferase for use in treatment and prevention of lysosomal storage diseases
07/24/2008US20080176284 Site specific incorporation of keto amino acids into proteins
07/24/2008US20080176283 Thermotoga neapolitana DSM 5068 alkaline phosphatase (PhoA) gene and recombinant enzyme production
07/24/2008US20080176282 Nucleotide sequences coding cellulase for use in textile treatment, cleaning products and production of ethanol
07/24/2008US20080176281 Transgenic cell for use as bioreactor in expression of polypeptide for treating arthritis
07/24/2008US20080176280 Chimeric retinoid x receptors and their use in a novel ecdysone receptor-based inducible gene expression system
07/24/2008US20080176279 HUMAN CYCLIN-DEPENDENT KINASE (hPNQALRE)
07/24/2008US20080176278 Two helix binders
07/24/2008US20080176277 Expanding the eukaryotic genetic code
07/24/2008US20080176258 Using Carbonic anhydrase expression in breast tissues as diagnostic indicator of cell proliferative disorders
07/24/2008US20080176252 Amyloid beta-derived diffusible ligands (ADDLs), ADDL-surrogates, ADDL-binding molecules, and uses thereof